Urologic Oncology Research Program
Using basic science and translational research to improve clinical outcomes of patients with prostate, kidney and bladder cancers.
The Uro-Oncology research program holds extramural funding and engages in research collaborations to advance knowledge and clinical translation. Currently, the program is funded by a National Cancer Institute Program Project on "Prostate Cancer Bone Metastasis: Biology and Targeting," and NIH R01, Department of Defense and foundation research grants.
Collectively, we pursue strong inter- and intra-programmatic collaborations with three objectives:
- Understanding the "cross-talk" between the tumor and its microenvironment
- Developing new imaging, targeting and biomarkers
- Accelerating clinical translation of basic science discoveries from bench to bedside to improve the clinical outcome of patients with prostate, kidney and bladder cancers.
Research Faculty
A team of nationally and internationally recognized scientists in the field of cancer biology guides urologic-oncology research at Cedars-Sinai.
Clinical Resources
For information on diagnostic testing and screening, prostate cancer treatments or to find a physician, please visit the following Cedars-Sinai clinical programs:
Have Questions or Need Help?
Contact us if you have questions or wish to learn more about the Urologic Oncology Research Program at Cedars-Sinai.
Uro-Oncology Research Program
8750 Beverly Blvd, Atrium 103
Los Angeles, CA 90048